Kyowa helps Kirin weather anaemia storm
This article was originally published in Scrip
Executive Summary
Kirin is looking to its expanded pharmaceutical business to deliver 22% of group operating profit in 2009, double the 2007 figure, boosted by the full integration later this year of the Kyowa Hakko business. This is already helping Kirin overcome falling sales in its main anaemia business.